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Abstract
Pre- and postnatal developmental studies of the lung have provided compelling evidence
demonstrating multiple factors that orchestrate alveolar epithelial cell differentiation. The extent to
which reactivation of certain developmental pathways in the adult might influence the course of
differentiation of alveolar type 2 cells (AT2) into AT1 cells is not known. In this study, we
examined selected members of the forkhead (Fox) family of transcription factors and the Wnt
(wingless) family of signaling proteins for expression during human alveolar cell differentiation in
vitro and determined their potential responses to sulfated components of extracellular matrix
(ECM), like those shed from cell surfaces or found in basement membrane and modeled by
heparin. Isolated adult human AT2 cells cultured over a nine day period were used to define the
temporal profile of expression of targeted factors during spontaneous differentiation to AT1 cells.
FoxA1 protein was up-regulated at early to intermediate time points, where it was strongly
elevated by heparin. Gene expression of Wnt7A increased dramatically beginning on day 3 and
was enhanced even further on days 7 and 9 by heparin, while protein expression appeared at days
7 and 9. These temporal changes of expression suggest that sulfated ECMs may act to enhance the
increase in FoxA1 at the critical juncture when AT2 cells commence the differentiation process to
AT1 cells, in addition to enhancing the increase in Wnt7A when the AT1 cell phenotype stabilizes.
Collectively, these factors may act to modulate differentiation and stabilize cell numbers in the
adult human pulmonary alveolus.
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INTRODUCTION
The pulmonary alveolus is populated by a simple epithelium of squamous type I cells (AT1)
and cuboidal type II (AT2) cells. The latter cells act as epithelial progenitors (Evans et al.,
1975), produce surfactant (Mason, 1987), and support host defense (Wright, 1997). Previous
work has shown that sulfated extracellular matrices (ECMs), such as heparan sulfate
proteoglycans (HSPGs) as modeled by heparin, significantly influence AT2 responses to
fibroblast growth factors (FGFs) as they relate to events associated with proliferation (Li et
al., 2002b; Newman et al., 2004; Sannes et al., 1998), gene expression (Leiner et al., 2006;
Li et al., 2002b), and protein synthesis (Li et al., 2002b). {{28 Li, C.M. 2002;}}. These
effects can occur directly at or before receptor binding at the cell surface (Fannon et al.,
2000), or indirectly at downstream signaling targets, such as MEK1/2, Erk1/2, SAP/JNK,
and Akt/PKB (Newman et al., 2004). Alternatively, heparin itself has been shown to bind to
cell surfaces and gain access to the cytoplasm and nucleus, where it could effect multiple
biologic targets (Castellot et al., 1985) The rationale for the current investigations built upon
earlier work in which the structural domains of the alveolar basement membrane associated
with AT2 cells were shown to be quantitatively less sulfated than those of AT1 cells in the
adult lung, wherein such differences could directly impact the biology of these cells (Grant
et al., 1983; Sannes, 1984; Van Kuppevelt et al., 1984).
From these studies grew the initial paradigm in which the low sulfate ECM environment
was predicted to promote the AT2 cell’s capacity to respond to growth factors, while the
high sulfate environment of the AT1 cell would retard/inhibit its responsiveness to the same
stimuli. It is now understood that the bioactivity of sulfated ECMs is dependent upon their
concentration within a microenvironment (Fannon et al., 2000; Kamimura et al., 2001), the
nature of the specific sulfate linkages (O-2-, O-6-, -N-, etc.) (Izvolsky et al., 2003; Luo et
al., 2006; Yuguchi et al., 2005), and their compositional characteristics (Sannes et al., 1996;
Shannon et al., 2003) and shed status (Kainulainen et al., 1998). While these data
demonstrate important roles for sulfated ECMs in defining alveolar cell proliferation, their
potential role in differentiation and cell fate specification remains unknown. More
importantly, the specific factors that control the differentiation of AT2 cells into AT1s in the
adult lung have yet to be defined.
A substantial body of work has demonstrated the importance of the forkhead (Fox) family of
transcription factors during lung development. Gene-targeted deletion of foxa1 results in
transient perturbation of epithelial maturation at precise points in embryonic and postnatal
development (Besnard et al., 2005). Deletion of foxa2 precludes formation of the lung bud,
resulting in early embryonic death, and its targeted deletion within a subset of lung
epithelium using an SP-C promoter construct gave newborn mice severe pulmonary disease
similar to respiratory distress syndrome (Wan et al., 2004b). These animals exhibited
abnormal, immature alveolar epithelium without lamellar bodies and lacked mature AT1
cells (Wan et al., 2004b). Similarly, animals with reduced expression of foxa1 and foxa2 had
inhibited cell proliferation, epithelial differentiation, and branching morphogenesis (Wan et
al., 2005). Foxa2 regulates a series of events that control alveolar epithelial cell maturation
and which are required for the transition to air breathing at birth (Wan et al., 2004b). These
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transcription factors, acting in concert with sulfated ECMs, could prove significant in
helping drive epithelial cell differentiation in the adult alveolus.
A compelling argument could also be made for involvement of the Wnt family of growth
factors in the limited reactivation of developmental pathways during alveolar turnover. The
Wnt proteins are well known regulators of proliferation, differentiation, adhesion, polarity,
and cell fate during lung development and morphogenesis (Borok et al., 2006; Pongracz and
Stockley, 2006; Shannon and Hyatt, 2004). Upon Wnt binding, either canonical pathways
(which involve activation of the key intermediate, β-catenin) or non-canonical pathways
independent of β-catenin (mediated through either c-Jun kinase/AP-1 [JNK/AP-1] or
calmodulin kinase II/nuclear factor of activated T cells [CaMKII/NFAT] pathways) are
activated. While Wnt2 is not required for the development of apparently normal lungs in
mice (Monkley et al., 1996), Wnt5a null mice have late-stage maturational lung defects (Li
et al., 2002a) and inactivation of Wnt7b results in defects in lung development (Shu et al.,
2002). Similarly, knockdown of Wnt signaling with β-catenin morpholinos results in
increased branching and cell proliferation in developing lungs in vitro (Dean et al., 2005).
Wnt proteins, like FGFs, signal in a very specific spatiotemporal fashion which appears to
be unique for each Wnt family member; it is noteworthy that they are highly influenced by
sulfated ECMs. This critical feature could be the key to alveolar epithelial cell
differentiation and, hence, their responses to injury. Previous studies have shown that Wnt
signaling in early stage embryos is dependent upon HSPGs for progression (Itoh and Sokol,
1994) and that Wnt11 expression by epithelium is dependent upon HSPG expression in the
neighboring mesenchyme (Kispert et al., 1996). The glycosaminoglycan components of
HSPGs have been shown to modulate extracellular localization and promote signaling of
Wnt1 in a sulfation-specific fashion (Baeg et al., 2001; Reichsman et al., 1996).
Accordingly, sulfated ECM-Wnt relationships, if operative in the adult pulmonary alveolus,
would be predicted to be important determinants of differentiation.
It was the goal of this study to examine the sequence of expression of several factors that
might be expected to control or otherwise influence the differentiation of AT2 cells into
AT1 cells in culture. From this study, we hoped to gain insights into the control of this
process in the adult whole lung which could lead to more targeted studies. To address this
important issue, the tendency of isolated AT2 cells to “spontaneously differentiate” into
AT1-like cells with time in culture (Dobbs et al., 1985; Manzer et al., 2006; Wang et al.,
2006) was exploited. Isolated adult human AT2 cells were cultured on collagen-coated
dishes and samples were harvested upon attachment (“day 0”) and at 1, 2, 3, 4, 7, and 9
days. RNA and protein were isolated and levels of selected factors monitored by gene and
protein expression assays. In addition, some cells were treated with heparin, a model of both
fixed (insoluble) and shed (soluble) sulfated ECMs, to assess whether sulfated components
of ECM potentially influence expression levels. Expression levels of Wnt7A, β-catenin, and
FoxA1, along with cell-type specific markers, were observed to vary with differentiation and
often also in response to the presence of heparin during the time course. These results
suggest potential role(s) for these factors and sulfated ECMs in the adult alveolar epithelium
during normal lung homeostasis or recovery from pulmonary injury.
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MATERIALS AND METHODS
Cell culture
Human alveolar type 2 cells were isolated by elastase digestion according to Dobbs (Dobbs,
1990) from cadaveric organ donor lung tissue obtained from the National Disease Research
Interchange (Philadelphia, PA). Preparations of cells from three different human lungs were
used in the experiments described herein. Where no statistical data is presented, the data
shown are reflective of representative results of the parameters evaluated. All human
specimens were handled under Institutional Review Board-approved protocols. The cells
were maintained in DMEM medium supplemented with 10% fetal bovine serum and
containing additional antibiotics (Amphotericin, Ceftazidime, Tobramycin and Vancomycin
at 1.25, 100, 80 and 100 μg/ml, respectively) for the first 2 days or a penicillin,
streptomycin, and amphotericin B cocktail with 50 μg/ml gentamicin thereafter. Cells were
cultured at 37°C under an atmosphere of 95% air and 5% CO2 in tissue culture dishes pre-
coated with type I collagen from calf skin (C-8919, Sigma, St. Louis, MO) or rat tail
collagen (BD Biosciences, Franklin Lakes, NJ) at a density of 0.06 μg/mm2. Cells were
cultured with or without high molecular weight heparin (Calbiochem, La Jolla, CA) at 500
μg/ml (3μM) for 1, 2, 3, 4, 7, or 9 days after overnight attachment. Cultures were terminated
by removing the media, rinsing the dishes once with PBS, and lysing the cells with buffer
unique for protein or RNA isolation.
Immunofluorescence
Cells cultured on collagen-coated glass coverslips and fixed in methanol were assessed by
immunofluorescence for the localization of pan-cytokeratin to identify epithelial cells and
for α-smooth muscle actin to identify contaminating myofibroblasts using commercially
available monoclonal antibodies (Cell Signaling Technology, Danvers, MA; and Sigma) and
FITC-labeled secondary antibodies (Vector Laboratories, Burlingame, CA). Nuclei were
demonstrated with DAPI. Digital photography was performed with a Nikon Optiphot
microscope using standard light excitation and filters.
Protein analysis
Western blot analysis of total proteins from AT2 cells from three individuals was performed
using standard protocols. Cell lysates in CLB (Cell Lysis Buffer; Cell Signaling
Technology) were sonicated (4 X 5 sec) and centrifuged (14,000 rpm, 20 min, at 4°C). The
total protein in each supernatant was quantified by a standard Bradford assay (Bio-Rad
Laboratories, Inc., Hercules, CA). Equal amounts of protein (35 μg) from each sample were
electrophoretically separated on NuPAGE 4–12% Bis-Tris gels in MES Running Buffer
(Invitrogen, Grand Island, NY) followed by transfer to nitrocellulose membranes. After
blocking for 1 hr in 5% milk in TBS-T [20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.1%
Tween 20], the blots were probed overnight at 4°C with antibodies in TBS-T/5% milk at
1:1000 dilution. Primary antibodies to activated β-catenin and pan-cytokeratin (Cell
Signaling Technology), FoxA1 (Novus Biologicals, Inc., Littleton, CO), Wnt7A, FoxA2,
and GATA-6 (R&D Bio-systems, Minneapolis, MN), PAI-1 (Plasminogen activator
inhibitor-1; Calbiochem), Nkx2.1/TTF-1 (Lab Vision Products, Thermo Fisher Scientific,
Fremont, CA), SP-C and aquaporin5 (Aqp5) (Santa Cruz Biotechnology, Santa Cruz, CA),
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and ACTA2/alpha-smooth muscle actin (Sigma) were used. Secondary antibodies (Cell
Signaling Technology) conjugated to horseradish peroxidase were diluted (1:4000 to
1:8000) in TBS-T with 5% nonfat dry milk. Specific bands were detected by
chemiluminescence using SuperSignal West Pico or SuperSignal West Dura Extended
Duration Substrate (Pierce Biotechnology, Rockford, IL) and visualized by autoradiography.
For normalization and quantification, the same blots were hybridized with anti-GAPDH
monoclonal antibody (Santa Cruz Biotechnology). Specific bands were scanned at 600 dpi
resolution and bitmapped images were quantified in LabWorks (UVP, Inc, Upland, CA).
Integrated Optical Densities (IOD) were normalized to GAPDH and graphed in Excel.
Quantitative Real-Time PCR
To obtain RNAs for gene expression studies, AT2/AT1-like cells were lysed in Buffer RLT
(RNeasy; Qiagen, Valencia, CA) directly in culture dishes. Total RNAs were purified using
the Qiagen RNeasy Mini Kit with on-column DNase digestion, and an equal amount of each
sample was reverse transcribed using the High Capacity cDNA Archive Kit (Applied
Biosystems, Foster City, CA). TaqMan primers and probes for Wnt7A (Hs00171699_m1),
and GAPDH (Hs99999905_m1) were obtained from Applied Biosystems and 100 ng of
each cDNA sample was amplified in duplicate or triplicate TaqMan qRT-PCR reactions on
the MyiQ iCycler (BioRad). For Wnt7A, reactions were normalized for the housekeeping
gene GAPDH and analyzed for gene expression using the REST-MCS program (Pfaffl et al.,
2002). Fold-change values were generated for each of three alveolar isolations and these
were combined and graphed, with error bars representing standard deviations from the
average fold change values.
RESULTS
AT2 cell preparation purity
Over 95% of isolated human AT2 cells in culture at day 1 stained positively for pan-
cytokeratin (Figs. 1A). By day 9 of culture, over 90% of the cells stained for pan-
cytokeratin, although the intensity of signal was slightly diminished due to their spreading
(Figs. 1B). Alpha-smooth muscle actin (ACTA2)-positive cells were sparse at day 1 (Figs.
1C). However, by day 9, approximately 4% of the total cell population demonstrated
ACTA2, confirming the relatively minor contribution of myofibroblasts to the cell
population during later time points (Figs. 1D).
Expression of AT2 and AT1 markers with heparin treatments
Pro-SP-C was strongly-expressed in isolated cells at days 0 and 1, reflecting the AT2
phenotype (Fig. 2). Pro-SP-C rapidly diminished thereafter, signaling the transition to the
AT1 phenotype, and its disappearance was accelerated by heparin treatments (Fig. 2).
PAI-1, a marker for the AT1 cell phenotype, was faintly detectable through day 2, began to
increase on day 3, and then was highly expressed on days 7 and 9 (Fig. 2). Aqp5, a marker
for the AT1 phenotype, rose steadily beginning on day 3 through day 9, indicating
progressive differentiation into an AT1-like phenotype (Fig. 2).
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Transcription factor expression
The transcription factor FoxA1 gradually increased from day 2 through day 9 (Fig. 3).
Levels of FoxA1 rose significantly with heparin treatment at early time points, while at later
time points (especially day 9), heparin treatment actually reduced FoxA1 protein expression
(Fig. 3). These conclusions were confirmed by densitometric tracings shown above the gels
(Fig. 3). FoxA2 expression gradually decreased after day 4 as the time course progressed to
day 9 (Fig. 4). GATA-6 protein was most highly expressed at days 0 and 1 and
progressively decreased through day 9 (Fig. 4). Nkx2.1/TTF-1 increased somewhat at day 1,
especially with heparin, and gradually decreased through day 9 (Fig. 4).
Wnt gene and protein expression
Commercial Wnt signaling pathway gene arrays (GE Arrays, ORN-043, Super Array
Biosciences, Frederick, MD) revealed differences in gene expression in rat alveolar cells due
to aging over 96 hours and significantly (>1.5-fold) differentially-expressed genes were
identified (data not shown). Wnt7A was found to be the most dynamically-expressed Wnt in
aging, and therefore differentiating, rat AT2 cells and was selected for examination in
human AT2 cells. Expression of Wnt7A was assessed in three different preparations of
isolated human alveolar cells as they progressed in culture over nine days and was found to
be highly elevated from day 3 through day 9. Of particular note is that treatment of cells
with heparin consistently and greatly increased Wnt7A gene expression at days 7 and 9 (Fig.
5). As variance between individuals was relatively small, the results of the fold change in
gene expression of three different isolates were combined (Fig. 5).
Wnt7A protein was below the limits of detection by Western blot until day 7, and was
increased at day 9 (Fig. 6). In contrast to the increased gene expression seen with heparin
treatments at days 7 and 9, there appeared to be a slight reduction in protein expression with
heparin addition (Fig. 6). Previous studies have noted that secreted Wnt proteins tend to
adhere to the cell membrane (Bradley et al., 1990; Smolich et al., 1993), so that our gene
expression data (Fig. 6) may be more realistic than quantitation of Wnt7A protein contained
in our mild lysates. The timing of the increased expression of Wnt7A protein paralleled an
increase at days 7 and 9 in dephosphorylated (active) β-catenin protein expression, above its
relatively steady level of expression for at least the first 4 days post-isolation (Fig. 6),
confirming increased activation of Wnt signaling pathway(s) concurrent with AT1
differentiation.
DISCUSSION
Numerous studies on alveolar development in the lung have provided critical data on factors
that control or modify spatial-temporal events involved with organ morphogenesis and cell
proliferation, differentiation, and cell fate (Dobbs et al., 1985; Manzer et al., 2006; Wang et
al., 2006). It was the goal of this study to examine in vitro several potential modulators of
alveolar epithelial cell differentiation and their response to the model for sulfated ECMs,
heparin, during the time course of isolated human AT2 cells’ phenotypic change into AT1-
like cells. The results demonstrate for the first time the reactivation of differentiation
pathways with expression of FoxA1 and the emergence of Wnt7A as a likely modulator of
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differentiation in isolated adult alveolar epithelial cells. Distinct changes in the levels of
expression of these proteins and their enhancement by heparin might be expected to reflect
changes in cell function and phenotype related to the process of AT1 cell replacement and
differentiation in vivo.
The forkhead transcription factors FoxA1 and FoxA2 are intriguing prospective players in
the modulation of alveolar differentiation in the adult. Targeted disruption of Foxa1 in mice
altered the timing of maturation of respiratory epithelium, such that delays were observed in
dilation of peripheral lung saccules at E16.5 and alveolarization at PN5 (Besnard et al.,
2005). In each case, however, these delays were met with compensatory growth that resulted
in subsequent normalization of the tissue within a short period (Besnard et al., 2005).
Similarly, Clara cell secretory protein (CCSP), pro-surfactant protein (SP)-C, and SP-B
protein expression were decreased in Foxa1−/− mice between E16.5 and E18.5, but were at
normal levels at birth (Besnard et al., 2005). These data support a role for Foxa1 in alveolar
epithelial cell maturation at very precise time points during development.
Deletion in early embryogenesis of the essential transcription factor Foxa2, when
conditionally targeted to peripheral pulmonary cells only, results in immature AT2 cells and
the absence of AT1 cells at birth (Wan et al., 2004b). However, when Foxa2 is deleted just
before birth, neonate lungs show no overt morphologic abnormalities but then accumulate
alveolarization and septation pathologies (Wan et al., 2004a). As Foxa1 and Foxa2 share
patterns of expression in respiratory epithelium and bind similar consensus DNA binding
sites, it may not be surprising that they serve similar functions in lung morphogenesis.
Foxa2 can compensate for the targeted deletion of Foxa1, and Foxa1 mRNA was enhanced
in animals in which Foxa2 was conditionally deleted (Wan et al., 2005). This study
demonstrated that Foxa1 and Foxa2 have overlapping as well as distinct roles in the control
of gene expression. It is likely that they interact and cooperate with a variety of other
transcription factors to drive patterns of expression during development (Minoo et al., 2007).
Both Foxa1 and Foxa2 are expressed in the normal adult lung (Besnard et al., 2004). Foxa2
expression may play an active role in regulation of the repair and redifferentiation of
bronchiolar epithelium following injury (Park et al., 2006), but little is known about the
function of Foxa1 in the adult.
The present data are consistent with a prominent role for FoxA1 in alveolar cell turnover in
the adult. FoxA1 expression was clearly upregulated during the temporal progression toward
the AT1 cell without heparin. But FoxA1 expression was significantly enhanced by heparin
treatment at early time points, suggesting a potentially important role for increased sulfated
ECMs in their soluble, shed forms or insoluble, fixed states, as found in the alveolar
basement membranes (Sannes, 1984). Foxa1 has been shown to be upregulated by TTF-1
binding to two sites in the Foxa1 promoter (Peterson et al., 1997). In our studies, TTF-1
protein increased soon after AT2 isolation and was slightly enhanced on day 1 by heparin
treatment. Heparin’s effects on TTF-1 could be part of the signal through which heparin
treatments increase FoxA1. FoxA2 was much more consistent over time and less affected by
heparin. Nevertheless, it is possible that FoxA1 and FoxA2 act in concert – with varying
sensitivities to a sulfated environment –perhaps ensuring progression of differentiation
regardless of the pericellular environment. But the facts that FoxA1 varies so directly with
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the progression of differentiation and that it is enhanced by modulators present in the
immediate pericellular environment (sulfated ECMs) make it an excellent candidate for
influencing, if not initiating, the differentiation process.
Although Wnt7a is not known to play any specific roles in lung development, it has been
shown to have antitumor effects in non-small cell lung carcinoma (NSCLC) (Winn et al.,
2005; Winn et al., 2006). In these studies, Wnt7a-transfection reversed transformation and
decreased anchorage-independent proliferation in NSCLC cell lines. Furthermore, Wnt7a
protein induced epithelial differentiation through induction of cadherin and Sprouty 4 and
through activation of peroxisome proliferator-activated receptor γ (PPARγ) by ERK-5
(Winn et al., 2005). In the present study, Wnt7A gene expression began a rapid increase
beginning at day 3 and continuing through day 9, with a clear enhancement with heparin
treatment (Fig. 8), as the cells assumed more of an AT1-like phenotype. What initiates this
rapid increase is not apparent, but a recent study demonstrated that TGFβ1, which has been
shown to up-regulate Wnt7a in bone marrow stromal cells (Zhou et al., 2004), increases
during in vitro trans-differentiation of rat AT2 to AT1 cells from days 1–5 (Bhaskaran et al.,
2007). Addition of excess TGFβ1 prior to proliferation inhibited AT2 proliferation and later
differentiation, while inhibition of TGFβ1 signaling after proliferation prevented
differentiation (Bhaskaran et al., 2007) – demonstrating the important role TGFβ1 at key
points in this process. Preliminary data from our lab has indicated that TGFβ1 protein and
Smad 2/3 signaling increases in human AT2 cells during differentiation in culture parallel to
the enhanced expression of Wnt7A as in Figure 8. It is established that TGFβ can suppress
surfactant protein gene expression in fetal lung AT2 cells (McDevitt et al., 2007) and
antagonize keratinocyte growth factor-induced AT2 cell proliferation (Zhang et al., 2004).
Interestingly, sulfated ECMs have been shown to inhibit proliferation (Li et al., 2002b;
Newman et al., 2004; Sannes et al., 1998) and AT2 cells in culture add progressively more
sulfate to their biosynthesized ECMs with time (Sannes et al., 1997). Wnt7A, TGFβ1, and
sulfated ECMs are likely to act in concert to significantly affect the inhibition/retardation of
proliferation and ensure stabilization of phenotype with progression toward the AT1-like
cell.
GATA-6 and TTF-1/Nkx2.1 regulate differentiation of alveolar epithelial cells (Wert et al.,
2002; Yang et al., 2002) and act synergistically to regulate lung specific gene expression and
development (Zhang et al., 2007). The data presented here demonstrate strong expression of
GATA6 and TTF-1 at early time points in culture while the cells are still presumed to be
AT2 cells, but over the 9-day time course, both factors diminish in expression. As these
proteins are known regulators of SP-C production (Liu et al., 2002), their lack of or reduced
expression in the day 9 post-isolation alveolar cell should not be surprising.
These data offer potentially important perspectives on the in vitro differentiation of AT2
cells to AT1-like cells. Of particular note was the level of gene and protein expression - and
heparin-induced regulation - of Wnt7A, which may not only play a role in differentiation
and cell fate of AT1 cells but may also affect their ability to proliferate under homeostatic
conditions. The temporal expression patterns of FoxA1 during early and intermediate time
points were not as surprising, but the change in expression of FoxA1 with heparin treatments
may be significant. Up-regulation at early times by heparin may mimic the effects on a
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newly-generated replacement alveolar cell of the heavily sulfated basal lamina associated
with AT1 cells in vivo (Grant et al., 1983; Sannes, 1984; Van Kuppevelt et al., 1984) and/or
the shedding of sulfated ectodomains of surface proteoglycans during injury (Kainulainen et
al., 1998). Following the asymmetric division of the limited stem-like AT2 cell to replace a
damaged AT1 cell, the first ECM encountered by the new (daughter) cell would be heavily
sulfated. This sulfated ECM could trigger enhancement of FoxA1 which, we believe, may
initiate progression toward the AT1 phenotype. Enhancement of Wnt7A by the sulfated
ECM could then stabilize the AT1 phenotype and prevent further proliferation. Collectively,
these factors are candidates for playing roles in the transition to AT1-like cells – possibly
driving differentiation and stabilizing phenotype while reducing proliferation. It may be
useful to consider the changes in expression observed – their parallels and temporal overlaps
– in the context of epithelial plasticity, wherein alterations in signaling via growth
stimulating or retarding events can produce different outcomes (Borok et al., 1998; Wang et
al., 2007). It is possible that the factors described here, among others, help modulate this
important process in an orchestrated sequence in the adult both in response to injury and in
normal alveolar turnover, while the precise mechanisms involved remain to be elucidated.
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Figure 1.
Immunofluorescent detection of pan-cytokeratin and smooth muscle actin (ACTA2) in
isolated human alveolar cell preparations counterstained with DAPI. (A) Over 95% of “day
1” cells appear to be pan-cytokeratin positive, reflective of their epithelial origin; (B) Over
90% of “day 9” cells remained pan-cytokeratin positive, although significantly larger in size
than “day 1” cells. (C) Cells positive for the myofibroblast marker ACTA2 at “day 1” in
culture are difficult to resolve; (D) Only a few scattered myofibroblasts staining for ACTA2
in “day 9” cells confirm the relative purity of the AT2 isolation. Bar in each = 80 μm.
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FIGURE 2.
Time course of markers of alveolar epithelium differentiation from AT2 to AT1 cells.
Prosurfactant protein-C (pro-SP-C; marker for AT2 cells), is highly expressed at days 0 and
1, but shows a distinct reduction beginning on day 2, although slightly less with heparin. At
days 3 and 4, heparin treatment accelerates the increasing reduction of pro-SP-C. No pro-
SP-C expression is evident at days 7 and 9. Plasminogen activator inhibitor-1 (PAI-1;
marker for AT1 cells), was faintly detectable at day 1 and steadily increased as the time
course progressed to day 9. Another marker for AT1 cells is aquaporin5 (Aqp5), which is
detectable at day 7, but was very evident by day 9. GAPDH of the same blots is shown for
normalization. Blots shown are representative of the similar results of three separate
experiments.
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FIGURE 3.
FoxA1 protein expression is affected by heparin. FoxA1 protein in whole cell lysates of
isolated human AT2 cells was analyzed by Western blot. Levels of FoxA1 steadily increased
from day 2 in untreated cells, as confirmed in the densitometric tracings (gray bars). FoxA1
was highly increased by heparin treatment (black bars) at days 2, 3, and 4 but was decreased
on days 7 and 9 by heparin. GAPDH of the same blot is shown as a loading control. For
normalization of FoxA1 densitometry, equal areas of GAPDH signal in each lane were
quantified to avoid signal overlap.
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FIGURE 4.
Other differentiation-related transcription factors in human alveolar cells are less affected by
heparin. FoxA2 protein expression peaked early in the time course, and steadily decreased
after day 4 and was relatively insensitive to heparin. GATA-6 protein expression peaked
early in the time course and diminished through day 9. TTF-1 expression was low at
isolation but strongly increased on day 1 postisolation, was moderately enhanced only at this
early time point by heparin, and then tapered off toward day 9. Blots shown are
representative of three similar results.
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FIGURE 5.
Wnt7A expression in isolated human alveolar type 2 cells varies with time and heparin
treatments. Quantitative real time polymerase chain reaction (qRT-PCR) using TaqMan
primers and probes was performed on cDNA equivalent to 100 ng of total RNA isolated
from human AT2 cells cultured with or without 500 μg/mL heparin for 0–9 days. The
absolute wnt7A gene regulation in cells from three individuals treated in separate
experiments with (▲) or without (●) heparin is depicted at each time point. The solid line
(—) connects the means of the expression at each time point in heparin-treated cells from
the three individuals while the broken line (---) connects the means of expression at each
time point in untreated cells. Wnt7A clearly increased rapidly from day 2 through day 9 and
was enhanced by heparin on days 7 and 9.
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FIGURE 6.
Wnt7A and β-catenin protein expression in whole cell lysates of isolated human alveolar
cells, analyzed by Western blot. Wnt7A protein expression was not detected by Western blot
until day 7 and increased on day 9. β-catenin protein expression remained relatively steady
from day 0 through day 4 and then was elevated at days 7 and 9, confirming activation of
Wnt signaling. Each of these proteins is shown with the GAPDH band from the same blot
for normalization; the temporal pattern was the same in each of three individuals, and
representative blots are shown.
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